Related Experiment Video
Updated: Nov 26, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Why remission is not enough: underlying disease mechanisms in RA that prevent cure
Georg Schett1,2, Yoshiya Tanaka3, John D Isaacs4,5
1Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.
Abstract:
Cure is the aspirational aim for the treatment of all diseases, including chronic inflammatory conditions such as rheumatoid arthritis (RA); however, it has only been during the twenty-first century that remission, let alone cure, has been a regularly achievable target in RA. Little research has been carried out on how to cure RA, and the term 'cure' still requires definition for this disease. Even now, achieving a cure seems to be a rare occurrence among individuals with RA. Therefore, this Review is aimed at addressing the obstacles to the achievement of cure in RA. The differences between remission and cure in RA are first defined, followed by a discussion of the underlying factors (referred to as drivers) that prevent the achievement of cure in RA by triggering sustained immune activation and effector cytokine production. Such drivers include adaptive immune system activation, mesenchymal tissue priming and so-called 'remote' (non-immune and non-articular) factors. Strategies to target these drivers are also presented, with an emphasis on the development of strategies that could complement currently used cytokine inhibition and thereby improve the likelihood of curing RA.
Insights
Achieving a cure for rheumatoid arthritis (RA) remains challenging. This review defines cure versus remission and explores obstacles like immune activation and remote factors to guide future RA cure strategies.
Area of Science:
- Rheumatology
- Immunology
- Inflammatory Diseases
Background:
- Cure is the ultimate goal for rheumatoid arthritis (RA) treatment, but has only recently become an achievable target.
- Significant research is needed to define 'cure' for RA and understand why it remains rare.
Purpose of the Study:
- To define the differences between remission and cure in rheumatoid arthritis (RA).
- To identify key factors (drivers) hindering the achievement of a cure for RA.
- To propose strategies for targeting these drivers to improve the likelihood of curing RA.
Main Methods:
- This review defines remission and cure in RA.
- It discusses underlying factors (drivers) that prevent cure, including immune activation and non-articular influences.
- It presents potential strategies to target these drivers.
Main Results:
- Remission and cure are distinct goals in RA management.
- Drivers of sustained immune activation and cytokine production impede RA cure.
- These drivers include adaptive immune system activation, mesenchymal tissue priming, and remote factors.
Conclusions:
- Targeting identified drivers could complement current therapies like cytokine inhibition.
- Developing strategies to overcome these obstacles is crucial for advancing towards a potential cure for RA.
- Further research is needed to refine the definition of cure and develop effective curative strategies for RA.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

